These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19637510)
21. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115 [TBL] [Abstract][Full Text] [Related]
22. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Gao Z; Gidding HF; Wood JG; MacIntyre CR Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic understanding and control of varicella-zoster virus infection. Asano Y Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794 [TBL] [Abstract][Full Text] [Related]
24. Clinical use of Oka live varicella vaccine. Kamiya H; Sakurai M; Ihara T; Ito M; Torigoe S; Ota Y; Kamiya T; Horiuchi K; Asano Y; Baba K Acta Paediatr Jpn; 1988 Oct; 30(5):594-600. PubMed ID: 2849859 [No Abstract] [Full Text] [Related]
26. Varicella vaccine studies in healthy children and adults. Arbeter AM; Starr SE; Plotkin SA Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494 [TBL] [Abstract][Full Text] [Related]
27. Proceedings of the 3rd International Conference on the Varicella-Zoster Virus. Palm Beach Gardens, Florida, USA. 9-11 March 1997. J Infect Dis; 1998 Nov; 178 Suppl 1():S1-112. PubMed ID: 9874603 [No Abstract] [Full Text] [Related]
28. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Balfour HH Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447 [TBL] [Abstract][Full Text] [Related]
29. Experience with live-attenuated varicella-zoster vaccines. LaRussa P Contrib Microbiol; 1999; 3():173-92. PubMed ID: 10599530 [No Abstract] [Full Text] [Related]
32. [Letter: Prevention against varicella and herpes zoster in individuals with impaired immunological defence]. Moe FJ Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2409. PubMed ID: 4374773 [No Abstract] [Full Text] [Related]
33. Varicella vaccine in children with chronic renal insufficiency. Broyer M; Boudailliez B Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466 [TBL] [Abstract][Full Text] [Related]
34. Clinical overview of varicella vaccine: development and early studies. Takahashi M Pediatrics; 1986 Oct; 78(4 Pt 2):736-41. PubMed ID: 3020493 [TBL] [Abstract][Full Text] [Related]
35. Varicella immunization and herpes zoster. Volpi A Herpes; 2005 Dec; 12(3):59. PubMed ID: 16393520 [No Abstract] [Full Text] [Related]
36. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Arvin AM Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912 [TBL] [Abstract][Full Text] [Related]
37. Effects of varicella vaccination on herpes zoster incidence. Wagenpfeil S; Neiss A; Wutzler P Clin Microbiol Infect; 2004 Nov; 10(11):954-60. PubMed ID: 15521996 [TBL] [Abstract][Full Text] [Related]
38. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039 [TBL] [Abstract][Full Text] [Related]
39. Prevention of shingles by varicella zoster virus vaccination. Holodniy M Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624 [TBL] [Abstract][Full Text] [Related]